Hepatic Transporters Alternations Associated with Non-alcoholic Fatty Liver Disease (NAFLD): A Systematic Review.

Navid OmidkhodaSimin ZareSina MahdianiSara SamadiFatemeh AkhlaghiAmir Hooshang Mohammadpour

Published in: European journal of drug metabolism and pharmacokinetics (2022)

Since extensive changes in hepatic transporters could alter the pharmacokinetics of the drugs and potentially affect the safety and efficacy of drugs, close monitoring of drug administration is highly suggested in patients with NASH.

Keyphrases

drug administration
drug induced
liver fibrosis